Form 4 for BMRN BIOMARIN PHARMACEUTICAL INC
Accepted 2022-07-11 00:00:00 ET · period of report 2022-07-08 · accession 0001567619-22-013886 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-07-11 | 2022-07-08 | BMRN | Davis George Eric | EVP, CLO | S - Sale | $90.00 | -7,398 | 58.9K | -11% | -$665.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-07-08 | S | D | 7,398 | $90.00 | 58,941 | D | — | — | (F1) Trade made pursuant to a 10b5-1 plan executed on March 4, 2022. |